Similar articles

• Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.

  Yano M, Shiozaki H, Inoue M, Tamura S, Doki Y, Yasuda T, Fujiwara Y, Tsujinaka T, Monden M. Yano M, et al. World J Surg. 2002 Sep;26(9):1155-9. doi: 10.1007/s00268-002-6362-0. Epub 2002 Jun 24. World J Surg. 2002. PMID: 12209246
• [Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin].

  Murakami M, Morikawa A, Okabe R, Hayashi K, Miyazawa K, Iijima S, Ozaki K, Suzuki A, Koyama Y, Sugiyama A. Murakami M, et al. Gan To Kagaku Ryoho. 2002 May;29(5):767-70. Gan To Kagaku Ryoho. 2002. PMID: 12040682 Japanese.
• [Preoperative intra-arterial and venous neoadjuvant chemotherapy for advanced gastric cancer].

  Murano A, Katsumata K, Yamamoto K, Kitamura K, Mori Y, Misaka T, Murohashi T, Yamashita S, Sumi T, Ashizawa T, Aoki T, Koyanagi Y, Hirota T. Murano A, et al. Gan To Kagaku Ryoho. 1998 Oct;25(12):1977-9. Gan To Kagaku Ryoho. 1998. PMID: 9797824 Japanese. No abstract available.
• The treatment of advanced gastric cancer.

  Wils J. Wils J. Semin Oncol. 1996 Jun;23(3):397-406. Semin Oncol. 1996. PMID: 8658224 Review.
• [Neoadjuvant chemotherapy in advanced stomach cancer--a case of complete response].

  Káposztás Z, Cseke L, Kalmár K, Horváth OP. Káposztás Z, et al. Magy Seb. 2002 Oct;55(5):321-4. Magy Seb. 2002. PMID: 12474518 Review. Hungarian.